Clinical studies recruiting near Heilongjiang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · Harbin medical university cancer hospital · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401 Indomethacin vs Diclofenac for Preventing PEP
NA · Air Force Military Medical University, China · NCT07071441 A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · AbbVie · NCT06487559 China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Phase N/A · Second Xiangya Hospital of Central South University · NCT05498974 A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Phase 2 · Abbisko Therapeutics Co, Ltd · NCT06668103 Rectal NSAIDs With/Without PD Stent for PEP Prevention
NA · Air Force Military Medical University, China · NCT07117318 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Bactiseal Catheter Safety Registry Study
Phase N/A · Integra LifeSciences Corporation · NCT06276543 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · Kunming Pharmaceuticals, Inc. · NCT07279493 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Bristol-Myers Squibb · NCT07291076 The Chinese Familial Alzheimer's Network
Phase N/A · Capital Medical University · NCT03657732 Mobile Applet for Weight Management in Obese Heart Failure Patients
NA · Heart Health Research Center · NCT06455878 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Eli Lilly and Company · NCT07415044 A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors
Phase 1 · Heronova Pharmaceuticals · NCT07071090 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · Bristol-Myers Squibb · NCT07361289 Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenoca
Phase 2 · Jiangsu HengRui Medicine Co., Ltd. · NCT07102901 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Turning Point Therapeutics, Inc. · NCT03093116 Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectiou
Phase N/A · Huashan Hospital · NCT05965128 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Pfizer · NCT07144280 A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectabl
Phase 2 · Innovent Biologics (Suzhou) Co. Ltd. · NCT06797297 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · RemeGen Co., Ltd. · NCT07105215 Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
Phase N/A · Huashan Hospital · NCT07694648 A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Phase 1/Phase 2 · Jiangsu HengRui Medicine Co., Ltd. · NCT06015048 A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1
Phase 1/Phase 2 · Allist Pharmaceuticals, Inc. · NCT05276726 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Phase 1/Phase 2 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367516 Chinese Psoriasis Real World Evidence Research
Phase N/A · the Second Affiliated Hospital of Harbin Medical Unviersity · Second Affiliated Hospital, Zhejiang University, School of M · NCT04465838

Look up another city

Look up another condition